Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | — | — | — | $87.0K | $132K | $37.7K | — | — |
| Revenue growth | — | — | — | — | — | — | 51.2% | -71.4% | — | — |
| Gross profit | $0.00 | $0.00 | — | — | — | — | — | — | — | — |
| Operating income | -$8.54M | -$6.72M | -$9.99M | -$15.9M | -$26.6M | -$15.8M | -$14.4M | -$20.9M | -$10.6M | -$9.36M |
| Operating margin | — | — | — | — | — | -18130.3% | -10964.6% | -55519.9% | — | — |
| Net income | -$7.01M | -$6.73M | -$9.91M | -$15.6M | -$26.4M | -$15.7M | -$14.3M | -$20.7M | -$10.6M | -$9.84M |
| Net margin | — | — | — | — | — | -18062.0% | -10864.0% | -54858.1% | — | — |
| EPS (diluted) | -$1.57 | -$1.37 | -$0.87 | -$0.37 | -$0.47 | -$0.14 | -$7.11 | -$9.18 | -$47.88 | -$4.56 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$7.08M | -$6.36M | -$9.08M | -$13.0M | -$17.0M | -$13.5M | -$15.2M | -$7.29M | -$8.60M | -$9.25M |
| Capital expenditures | $27.2K | — | $125K | $25.2K | — | $43.9K | $128K | — | — | — |
| Free cash flow | -$7.10M | — | -$9.20M | -$13.0M | — | -$13.5M | -$15.4M | — | — | — |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $4.08M | $6.17M | $20.2M | $18.3M | $17.6M | $27.3M | $11.4M | $3.48M | $865K | $4.40M |
| Total assets | $4.31M | $7.21M | $22.0M | $19.8M | $18.7M | $28.2M | $14.8M | $4.97M | $1.47M | $10.1M |
| Total liabilities | — | — | — | — | — | — | — | $1.80M | $1.68M | $1.79M |
| Shareholders' equity | $2.97M | $6.32M | $20.9M | $17.2M | $16.8M | $26.5M | $13.0M | $3.17M | -$212K | $8.28M |
| Retained earnings | -$94.7M | -$101M | -$111M | -$127M | -$154M | -$171M | -$186M | -$206M | -$217M | -$227M |
| Shares (wtd avg diluted) | 4.91M | 4.93M | 29.4M | 46.1M | 91.8M | 1.94M | 2.01M | 2.25M | 221K | 2.16M |
Every figure is extracted from ORAGENICS INC’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.